320.00CHF-0.47%Mkt Cap: 256.43B CHFP/E: 20.11Last update: 2026-05-13
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas o…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)20.11
P/E (Forward)14.82
PEG—
P/B7.59
P/S4.05
EV/EBITDA11.57
EV/Revenue4.39
EPS (TTM)16.03
EPS (Forward)21.65
Cash Flow & Leverage
FCF Yield4.30%
FCF Margin17.41%
Operating CF18.85B CHF
CapEx (TTM)5.78B CHF
Net Debt/EBITDA0.74
Net Debt17.71B CHF
Technical
SMA 50346.73 (-7.7%)
SMA 200296.65 (+7.9%)
Beta0.21
S&P 52W Chg24.23%
Avg Vol (30d)866.22K
Avg Vol (10d)1.51M
Technical Indicators
RSI (14)50.4
MACD-0.4626
MACD Signal-1.0243
MACD Hist.+0.5617
BB Upper324.87 CHF
BB Middle318.90 CHF
BB Lower312.93 CHF
BB Width3.75%
ATR (14)6.469 CHF
Vol Ratio (20d)0.74x
52W Range
243.9058% of range374.90
52W High374.90 CHF
52W Low243.90 CHF
Profitability
Gross Margin73.73%
EBITDA Margin37.95%
Profit Margin20.33%
Oper. Margin29.99%
ROE38.10%
ROA12.79%
Revenue Growth-0.40%
Earnings Growth171.30%
Balance Sheet
Debt/Equity0.98
Current Ratio1.38
Quick Ratio1.05
Book Value/Sh42.48 CHF
Cash/Share19.46 CHF
Dividends
Fwd Div Rate9.800 CHF
Trail. Div Rate9.800 CHF
Div. Yield3.03%
5Y Avg Yield3.29%
Payout Ratio60.47%
Ex-Div DateMar 12, 2026
Pay Date—
Splits
Last Split100:1
Split DateMay 4, 2001
Ownership
Shares Out.688.93M
Float721.79M
Insiders—
Institutions—
Analyst Consensus
Rating2.4 (Buy)
Target (Mean)364.79 CHF
Target Range230.00 CHF – 428.00 CHF
# Analysts19
Company
Market Cap256.43B CHF
Enterprise Value278.22B CHF
Revenue (TTM)63.36B CHF
Gross Profit46.71B CHF
Net Income (TTM)12.88B CHF
Revenue/Share79.59 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
Last Price320.00 CHF
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012032048